Centro Médico Teknon
Bladder cancer treatment cost in Spain typically starts with essential diagnostics like a PET/CT scan, which costs $1,300 to $1,800. Primary surgical interventions such as bladder removal range from $25,000 to $35,000, while more complex bladder removal with reconstruction runs $25,000 to $40,000. Final expenses depend on the cancer stage, surgical approach, and clinic tier. Patients often find 30-50% savings compared to the US. Top treatment hubs include Barcelona and Madrid.
Typical Bladder Cancer Treatment Costs in Spain
Bookimed Expert Insight: Patients seeking peak surgical expertise should consider Hospital Quiron Barcelona. Dr. Antonio Alcaraz is a global pioneer with over 500 successful robotic procedures. For advanced cases, Centro Médico Teknon offers immunotherapy protocols following US Memorial Sloan Kettering Cancer Center guidelines. These specialized Keytruda packages start around $14,500. JCI-accredited facilities in Madrid and Barcelona ensure high-tier safety standards for complex reconstructions.
| Turcja | Austria | Hiszpania | |
| Usunięcie pęcherza moczowego z rekonstrukcją | od $15,000 | od $32,000 | od $25,000 |
| Usunięcie pęcherza moczowego | od $8,000 | od $22,000 | od $25,000 |
| Terapia Aktynem-225 | od $22,955 | od $55,000 | od $45,000 |
| Radioterapia raka odbytnicy | od $7,000 | od $12,000 | od $10,000 |
| Immunoterapia Keytruda (Pembrolizumab) | od $3,300 | od $15,000 | od $15,000 |
Wykonuje ponad 500 operacji urologicznych, w tym małoinwazyjne zabiegi z wykorzystaniem systemu robotycznego Da Vinci.
Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.
He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.
Dr López-Ibor specjalizuje się w onkologii dziecięcej i posiada ponad 20-letnie doświadczenie. Obecnie kieruje Oddziałem Hematologii i Onkologii Dziecięcej w szpitalu HM Montepríncipe.
Ponad 140 opublikowanych prac z zakresu onkologii urologicznej – dr Mellado Gonzalez kieruje badaniami nad rakiem pęcherza moczowego w Hospital Clínic de Barcelona.